TIA Clinical Trials in Paris, Paris
5 recruitingParis, Paris, France
Showing 1–5 of 5 trials
Recruiting
Phase 2
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.180 enrolled59 locationsNCT07029581
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Partial LipodystrophyGeneralised Lipodystrophy
Chiesi Farmaceutici S.p.A.100 enrolled28 locationsNCT02325674
Recruiting
Phase 2Phase 3
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
DementiaAlzheimers DiseaseAlzheimers Disease, Familial
Washington University School of Medicine280 enrolled35 locationsNCT05552157
Recruiting
Phase 2Phase 3
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
DementiaAlzheimers DiseaseAlzheimers Disease, Familial
Washington University School of Medicine280 enrolled35 locationsNCT06647498
Recruiting
Phase 3
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Stroke, IschemicStrokeAtherosclerosis+5 more
Assistance Publique - Hôpitaux de Paris2,800 enrolled1 locationNCT05476991